CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics

JSON

Felices M, Sarhan D, Brandt L, Guldevall K, McElmurry R, Lenvik A, Chu S, Tolar J, Taras E, Spellman SR, Warlick ED, Verneris MR, Cooley S, Weisdorf D, Blazar BR, Onfelt B, Vallera D, Miller JS

Blood 128 (22) 4291-4291 [2016-12-02; online 2016-12-02]

DOI 10.1182/blood.v128.22.4291.4291

Crossref 10.1182/blood.v128.22.4291.4291